Stimulation of NF-κB activity by the HIV restriction factor BST2. - Wikidata - awgldk - TriplyDB

Stimulation of NF-κB activity by the HIV restriction factor BST2.

Stimulation of NF-κB activity by the HIV restriction factor BST2.

http://www.wikidata.org/entity/Q39230459

about

Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1 Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection.The role of BST-2/Tetherin in host protection and disease manifestation Host-pathogen interaction in HIV infection Mechanism of HIV-1 virion entrapment by tetherin Characterization of red-capped mangabey tetherin: implication for the co-evolution of primates and their lentiviruses Counteraction of the multifunctional restriction factor tetherin Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses.Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.Tetherin/BST-2: Restriction Factor or Immunomodulator?Tetherin Antagonism by HIV-1 Group M Nef Proteins.Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin.Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey.Mouse knockout models for HIV-1 restriction factors.Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.Epitope tags beside the N-terminal cytoplasmic tail of human BST-2 alter its intracellular trafficking and HIV-1 restriction The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus release The sheep tetherin paralog oBST2B blocks envelope glycoprotein incorporation into nascent retroviral virions Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells.Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly BST2/tetherin inhibition of alphavirus exit.Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins.Innate immune evasion by filoviruses Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs.Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-κB Activation.Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

P2860

Q24297949-495C576B-6871-423E-B94D-C2711A459443 Q24701738-768E9C8E-D998-48F1-ACD3-574750D33AC3 Q26752737-6FB98598-C7B6-4A8A-A372-4D0F489A7AF1 Q27009024-058137F2-69C2-4E4D-91D9-6C664B5A0FF8 Q28534707-D078028F-D766-4574-AA2E-71C65DD7C74D Q28656415-ECB1FEC3-18EF-41DD-95E1-ED2BAC97BC9D Q28659945-11655995-7F17-4891-A14F-AEE9A3C61AFA Q30359547-6FD26BDA-E45F-4F94-8029-85285B7671FC Q30360141-AD657495-0191-4BF7-BA57-66A056EFFF8E Q30369981-4697FC12-C87B-4188-BE65-2632333A06E3 Q30385433-E3F895E1-DEE6-459F-B0A2-B05C3B704BE0 Q30393226-F5D16779-6E9E-45C5-ACCB-A2AD1759121F Q30397332-97F20E02-ED9B-4787-8463-0A53FFD3FAB6 Q30853698-B9907BE2-D8DF-4327-B954-B9B397F19E13 Q33292303-8541407F-057A-40E5-95CD-32B60E7F8F63 Q33674461-4E924D2F-89B4-4661-B96F-AFD21E5076AB Q33887674-57C903E6-BF07-4A0B-967B-6D2C735ECF16 Q34059163-7311DA2B-8F1A-496B-BF69-5E96D33360C2 Q34123690-8562086B-C7C3-455C-B0D3-74C38746D51D Q34161853-251102F2-3D2A-4953-99FC-BEBD4ACFAD3C Q34180302-5EC8C88F-DF9B-4EC0-AB4A-486587AF5724 Q34408687-0CFF9000-E333-416A-A48B-05BCCFD62DEC Q34594080-233065D8-F3F0-46D2-9671-628C29C0030C Q34615002-1010529B-169D-4F2E-A746-B617A6B40BE6 Q34929498-B2C5A42D-07C4-4F0F-8266-FDBFB989BB83 Q34992656-1AB63AF7-4D0F-4C56-B6F1-D2B59691CB46 Q35021021-48968283-7482-4F15-860F-EA054A100F72 Q35097640-62545E01-F9B6-4EB5-8BC0-4A8222F9A888 Q35362935-DAFBE7C5-58A9-4352-A31D-57DD7F24B72E Q35405550-B47F4BE3-BD3A-48B9-96B0-4606E8747BCE Q35536281-EF870F51-57FF-4A27-99ED-2B4E72073BDB Q35544442-0D81CDE7-392C-4590-A5D3-CA5B10660EAE Q35549043-E3F760E4-752D-49AA-9752-8F13E144C642 Q35582244-965EEF53-2105-4D8F-A4B1-3CD506BB7379 Q35582429-1F35A2BA-70A4-42AF-845E-01140CBD4CC4 Q35629426-77CB5745-8BDB-494B-A30E-77C47BBCE068 Q35758867-8C389910-E802-4A76-88AC-823D8377C601 Q35778560-1B6CCA4A-1BE7-470B-87AB-763D86626D84 Q35792954-D591B406-EA81-46D4-890B-0446F9C02C31 Q35840924-063F72F2-5944-4E96-A33E-2EDB36DA99FF

P2860

Stimulation of NF-κB activity by the HIV restriction factor BST2.

http://www.wikidata.org/entity/Q39230459

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@en

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@nl

type

label

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@en

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@nl

prefLabel

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@en

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@nl

P1433

Q39230459-DE539313-05C4-4231-A9F4-9F2FB7A71908

P1476

Q39230459-DC9A0B35-E70C-4A38-B914-A159FBEA854F

P2093

Q39230459-2D0D015E-D4CC-4739-AF1E-FF694B8A7520

Q39230459-3E845B87-FA82-4B13-AB39-B86A42872E45

Q39230459-3EFEE9AD-593E-482B-B090-E4C29EE8F713

Q39230459-5B4C3B07-47A2-4572-A480-558B16621055

Q39230459-BC4C2091-109A-400D-990F-D1E4ABF08235

Q39230459-C3EBD21C-05C1-48D7-A819-B1D240ACB087

P2860

Q39230459-08974228-2C45-46E2-92B7-F5A9772EA534

Q39230459-14C2E48D-2A92-446D-BDC3-9011171EFCDF

Q39230459-20C82229-0DDC-4458-B19A-593B5E37A43E

Q39230459-2303C40D-4FE3-4BB3-8F7F-14EC8CA67584

Q39230459-3D3D68AB-7E8A-48BE-BC8E-CB533D7342F0

Q39230459-3EAE5DF9-F4C6-44A6-AF7E-7BB77788AEC9

Q39230459-40B31290-4BF5-449E-9E0B-88B20EA9478E

Q39230459-5AA22AB4-F2F3-4E85-B10E-8D8EDB42C9BB

Q39230459-5B6E0970-5473-42C4-92B0-2AA273ED040A

Q39230459-617028BB-1FFD-4AA8-A464-37041F02AFCF

P304

Q39230459-F2E65109-53A9-408C-B319-7833EA423ED8

P31

Q39230459-0D96E90A-CCD3-44FE-9829-4BED6F8CA0A3

P356

Q39230459-DC7AFD9C-06BE-4EFE-95CC-05BBF752B582

P407

Q39230459-C2991417-6543-4F7D-BA80-D75249671227

P433

Q39230459-0E8A4B38-C17F-4BF7-8814-32A268203C28

P478

Q39230459-27AE64BA-623D-4745-908A-719CBB609C63

P577

Q39230459-01550D48-D86B-47B4-A025-61E5ACF7174E

P698

Q39230459-A9FD45A2-6D20-4C47-B24E-409B0A7D4C0E

P921

Q39230459-B2749AC6-2EFF-4FA4-848C-DB67B78FC56B

P932

Q39230459-A7B57214-8708-4D35-99D3-97B51284D924

P356

P1433

Journal of Virology

P1476

Stimulation of NF-κB activity by the HIV restriction factor BST2.

@en

P2093

Andrey Tokarev

http://www.w3.org/2001/XMLSchema#string

John Guatelli

http://www.w3.org/2001/XMLSchema#string

Kathleen Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Marissa Suarez

http://www.w3.org/2001/XMLSchema#string

Rajendra Singh

http://www.w3.org/2001/XMLSchema#string

Wilson Kwan

http://www.w3.org/2001/XMLSchema#string

P2860

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

TRIM5 is an innate immune sensor for the retrovirus capsid lattice

Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin

P304

2046-2057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02272-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23221546

http://www.w3.org/2001/XMLSchema#string

P921

P932

3571454

http://www.w3.org/2001/XMLSchema#string